MICROBIAL ENZYMES FOR REDUCTION OF ALPHA-GALACTOSE FROM COLLAGEN BASED TISSUE
Methods for preparing a non-human tissue matrix for transplantation are provided.
1 . A method for preparing a non-human tissue matrix for transplantation, comprising:
contacting a collagen-containing tissue matrix with an isolated Trichoderma reesei or Clostridium cellulyticum alpha-galactosidase in an amount and for a time sufficient to remove an α-gal epitope from the tissue matrix, thereby preparing the tissue matrix for transplantation into a human patient.
2 . The method of claim 1 , wherein the alpha-galactosidase comprises an amino acid sequence having at least 85% identity to the entire amino acid sequence set forth in a sequence selected from the group consisting of SEQ ID NOs:2, 4, 6, and 8.
3 . The method of claim 1 , wherein the alpha-galactosidase is encoded by a nucleic acid molecule comprising a nucleotide sequence having at least 85% identity to the entire nucleotide sequence set forth in a sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, and 7.
4 . The method of claim 1 , wherein the alpha-galactosidase is encoded by a nucleic acid molecule, said nucleic acid molecule encoding a protein comprising an amino acid sequence having at least 85% identity to the entire amino acid sequence set forth in a sequence selected from the group consisting of SEQ ID NOs:2, 4, 6, and 8.
5 . The method of claim 1 , wherein the tissue matrix is an acellular tissue matrix.
6 . The method of claim 1 , wherein the tissue matrix comprises a dermal tissue matrix.
7 . The method of claim 1 , wherein the tissue matrix is obtained from a tissue selected from fascia, pericardial tissue, dura, umbilical cord tissue, placental tissue, cardiac valve tissue, ligament tissue, tendon tissue, arterial tissue, venous tissue, neural connective tissue, urinary bladder tissue, ureter tissue, and intestinal tissue.
8 . The method of claim 1 , further comprising treating the tissue matrix to remove at least some of the cells and cellular components from the tissue matrix.
9 . The method of claim 8 , wherein the tissue matrix is treated to remove substantially all cells and cellular components prior to contacting the tissue matrix with the alpha-galactosidase.
10 . The method of claim 8 , wherein substantially all the cells and cellular components are removed from the tissue matrix.
11 . The method of claim 1 , wherein the at least one collagen-containing tissue matrix includes two or more tissue matrices.
12 . The method of claim 1 , further comprising packaging the tissue matrix.
13 . The method of claim 1 , further comprising sterilizing the tissue matrix.
14 . A tissue matrix prepared according to the method of claim 1 .